Bli medlem
Bli medlem

Du är här


Hofseth Biocare ASA : AGM - approval of private placement and a raise of a convertible bond loan

The AGM in Hofseth BioCare were held in Moloveien, Ålesund on Tuesday 26 May

All propsals were approved in accordance with the attached minutes from the

A statement from the Company's auditor regarding conversion of debt is
attached (in Norwegian only).

A prospectus in regards to the listing of the shares issued under the private
placement will be published as soon as it is approved by the Norwegian FSA.
Reference is made to the subscription form for the private placement on the

For further information, please contact:

Jon Olav Ødegård, CEO Hofseth BioCare ASA
Tel: +47 936 32 966
E-mail: joo@

Øystein Omvik, CFO Hofseth BioCare ASA
Tel: +47 936 99 400

About Hofseth BioCare:
Hofseth BioCare is a Norwegian biotech company that offers high-value
ingredients and finished products for humans and pets. The company is founded
on the core values of sustainability, traceability and optimal utilization of
natural resources. Through an innovative hydrolysis technology, Hofseth
BioCare is able to preserve the quality of salmon oil, proteins and calcium,
prepared of fresh salmon off-cuts. HBCs objective is to contribute to the
efficient use of marine resources and deliver quality products for
ingredients and finished consumer products in the nutrition market.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.



This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Hofseth Biocare ASA via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.